Reasons to Add HealthEquity Stock to Your Portfolio for Now

HealthEquity (HQY) reported a strong second-quarter fiscal 2026, driven by significant expansion in its Health Savings Account (HSA) offerings, which now total 10 million accounts (up 6% year-over-year) and $33.1 billion in assets (up 12% year-over-year). The company's strategic investments in AI and digital innovation are enhancing operational efficiency, customer engagement, and long-term margin potential, contributing to positive fiscal 2026 estimate revisions and a projected 21.7% growth over the next five years. However, a key concern remains data security threats, as HQY handles sensitive financial data, evidenced by approximately $1.2 million in fraud-related reimbursements in Q2 fiscal 2026, posing ongoing operational and reputational risks.

Analysis

HealthEquity (HQY) demonstrated robust performance in Q2 fiscal 2026, exceeding expectations with solid top-line and bottom-line growth, alongside improved operating and gross margins. The company's Health Savings Account (HSA) offerings continue to expand significantly, with total HSA assets increasing 12% year-over-year to $33.1 billion and the number of non-bank custodian HSAs reaching 10 million, up 6% year-over-year. This expansion underscores strong market penetration and asset accumulation.

Strategic investments in AI and digital innovation are driving scalable efficiency and enhancing customer engagement. HQY's AI-powered claims adjudication system and Agentic AI initiatives are reducing servicing costs and improving member satisfaction, while cloud migration boosts platform speed and reliability. These technological advancements are expected to strengthen long-term margin potential and customer loyalty.

The positive outlook is further supported by a projected 21.7% growth over the next five years and positive estimate revisions for fiscal 2026, with EPS estimates rising to $3.86. Despite strong operational performance, data security threats remain a significant concern, as HQY reimbursed $1.2 million for fraud-related incidents in Q2 fiscal 2026. The ongoing risk of a material breach poses potential for litigation, reputational harm, and operational disruption, which could temper the otherwise strong growth narrative.

Key Decisions for Investors

• Investors should consider HealthEquity's consistent HSA growth and strategic AI investments as key drivers for its long-term revenue and margin potential.
• Closely monitor the company's ongoing efforts and expenditures related to data security and fraud prevention, as these represent a material operational and reputational risk.
• Evaluate HQY's relative share performance against broader market indices, noting its 9.5% gain over six months significantly underperformed the S&P 500's 28.3% rise during the same period.